Adma Biologics | ADMA - Cost Of Sales

Stock Price
9.66
Daily Change
-0.17 -1.73%
Monthly
-38.90%
Yearly
-50.18%
Q2 Forecast
8.91

Adma Biologics reported $50.4M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Adma Biologics USD 50.4M 8.24M Dec/2025
Alnylam Pharmaceuticals USD 267.72M 67.57M Dec/2025
BioCryst Pharmaceuticals USD 9.52M 7.34M Dec/2025
Minerva Neurosciences 386K 31K Jun/2024
Novavax USD 22.1M 608K Dec/2025
Omeros USD 33.16M 18.52M Jun/2024
Takeda JPY 401.15B 184.07B Dec/2025